![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 7
2022
Friedrich, M. E.; Grohmann, R.; Rabl, U.; Winkler, D.; Konstantinidis, A.; Engel, R.; Seifert, J.; Toto, S.; Stubner, S.; Frey, R. und Kasper, S.
(2022):
Incidence of Drug-Induced Delirium During Treatment With Antidepressants or Antipsychotics: A Drug Surveillance Report of German-Speaking Countries Between 1993 and 2016.
In: International Journal of Neuropsychopharmacology, Bd. 25, Nr. 7: S. 556-566
2020
McAllister-Williams, R. H.; Arango, C.; Blier, P.; Demyttenaere, K.; Falkai, P.; Gorwood, P.; Hopwood, M.; Javed, A.; Kasper, S.; Malhi, G. S.; Soares, J. C.; Vieta, E.; Young, A. H.; Papadopoulos, A. und Rush, A. J.
(2020):
The identification, assessment and management of difficult-to-treat depression: An international consensus statement.
In: Journal of Affective Disorders, Bd. 267: S. 264-282
2017
Gastpar, M.; Müller, W. E.; Volz, H. P.; Möller, H. J.; Schläfke, S.; Dienel, A. und Kasper, S.
(2017):
Silexan does not cause withdrawal symptoms even when abruptly discontinued.
In: International Journal of Psychiatry In Clinical Practice, Bd. 21, Nr. 3: S. 177-180
Sturgess, R.; Palmer, D.; Trojan, J.; Hoffmeister, A.; Neu, B.; Kasper, S.; Dechêne, A.; Jürgensen, C.; Schirra, J.; Jakobs, R.; Høgset, A. und Finnesand, L.
(2017):
Phase I clinical study with photochemical internalisation, a novel technology for treatment of perihilar cholangiocarcinoma.
In: Journal of Hepatology, Bd. 66, Nr. 1:
S452-S452
2016
Modest, D. P.; Kasper, S.; Stintzing, S.; Prasnikar, N.; Müller, L.; Caca, K.; Gökkurt, E.; Fischer von Weikersthal, L.; Kopp, H.-G. und Trarbach, T.
(2016):
Randomized phase II study of maintenance treatment with 5-FU/FA plus panitumumab vs 5-FU/FA alone after induction (mFOLFOX6 plus panitumumab) in patients with RASWT metastatic colorectal cancer.
In: Annals of Oncology, Bd. 27
Rüssel, J.; Einem, J. von; Keilholz, U.; Dietz, A.; Grünewald, V; Maschmeyer, G.; Kasper, S.; Rupprecht, M.; Sasse, B.; Melillo, G. und Krauss, J.
(2016):
RAPTOR, the global phase II, III clinical development program of the PD-L1 inhibitor Durvalumab (MEDI4736) in 2nd-line recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) - A German update on the HAWK, EAGLE and CONDOR trials.
In: Oncology Research and Treatment, Bd. 39: S. 173-174
1998
Danos, P.; Kasper, S.; Grunwald, F.; Klemm, E.; Krappel, C.; Broich, K.; Hoflich, G.; Overbeck, B.; Biersack, H. J. und Möller, Hans-Jürgen
(1998):
Pathological regional blood flow in opiate-dependent patients during withdrawal: A HMPAO-SPECT study.
In: Neuropsychobiology, Nr. 4: S. 194-199
[PDF, 326kB]